1. Home
  2. GIC vs DMRA Comparison

GIC vs DMRA Comparison

Compare GIC & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Industrial Company

GIC

Global Industrial Company

HOLD

Current Price

$39.60

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$29.00

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIC
DMRA
Founded
1949
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GIC
DMRA
Price
$39.60
$29.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$43.00
AVG Volume (30 Days)
119.1K
306.7K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
3.44%
N/A
EPS Growth
17.09
121.48
EPS
1.38
N/A
Revenue
$1,379,100,000.00
N/A
Revenue This Year
$5.72
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
$28.71
N/A
Revenue Growth
4.80
N/A
52 Week Low
$26.40
$16.50
52 Week High
$40.71
$34.89

Technical Indicators

Market Signals
Indicator
GIC
DMRA
Relative Strength Index (RSI) 68.34 46.05
Support Level $38.16 $28.16
Resistance Level $40.71 $34.23
Average True Range (ATR) 0.89 1.50
MACD -0.12 -0.25
Stochastic Oscillator 62.72 4.72

Price Performance

Historical Comparison
GIC
DMRA

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw material.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: